Surgery and Adjuvant Hormonal Therapy Less Effective for Older Patients With Breast Cancer

Surgery and Adjuvant Hormonal Therapy Less Effective for Older Patients With Breast Cancer
Surgery and Adjuvant Hormonal Therapy Less Effective for Older Patients With Breast Cancer

Studies regarding the effect of treatment on the physical functioning of older patients with breast cancer are limited. A group of researchers sought to examine physical functioning in various age brackets of patients who were enrolled in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) phase III trial.

The researchers, led by Marloes Derks, Leiden University Medical Center, Leiden, The Netherlands, measured physical activity in metabolic equivalent of task (MET) hours/week at 1 and 2 years posttreatment intervals. Linear regression analysis was used to determine decreases in physical function. The 431 respondents were separated into 3 age brackets (younger than 60 years, 60 to 69 years, and older than 69 years) and their functioning reviewed via the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 questionnaire. 

Decreases in physical function were observed in all age brackets. The eldest age bracket was independently linked to physical atrophy. Patients in the 70+ years age bracket also demonstrated a lesser responsiveness to adjuvant hormonal therapy and breast surgery, compared to the other age brackets. The study authors stated that age-specific guidelines that factor in treatment consequences and quality-of-life considerations for older patients are needed.

Reference

1. Derks M, Glas N, Bastiaannet E, et al. Physical functioning in older patients with breast cancer: a prospective cohort study in the TEAM Trial. Oncologist. 2016 Jul 1. doi: 10.1634/theoncologist.2016-0033. [Epub ahead of print]

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs